Cannapowder (CAVG) 10-Q 14 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 14, 2019
Document And Entity Information
Entity Registrant Name	CANNAPOWDER, INC.
Entity Central Index Key	0001086082
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		12,403,052
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 68,855	$ 606,245
Marketable Securities		108,164
Prepaid expenses	17,256	12,847
Total current assets	86,111	727,256
Total assets	86,111	727,256
Current liabilities:
Accounts payable and accrued liabilities		25,159
Accounts payable to related party
Total current liabilities		25,159
Total liabilities		25,159
Stockholders' equity
Common stock, par value $0.00001 per share, 495,000,000 common shares authorized, 5,000,000 preferred shares authorized; 12,403,052 and 10,518,226 shares issued and outstanding at September 30, 2019 and December 31, 2018 respectively.	124	105
Accumulated other comprehensive income (loss)	5,338	(173,832)
Non-controlling interest	(96,447)	(37,893)
Stock Payable		15,000
Additional paid in capital	5,944,356	4,472,095
Accumulated deficit	(5,767,260)	(3,573,378)
Total stockholders' equity	86,111	702,097
Total liabilities and stockholders' equity	$ 86,111	$ 727,256

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	495,000,000	495,000,000
Preferred stock, shares authorized	5,000,000	5,000,000
Common stock, shares issued	12,403,052	10,518,226
Common stock, shares outstanding	12,403,052	10,518,226

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Revenues
Expenses:
Research and Development expenses	(37,865)	(45,321)	(120,307)	(102,202)
General and Administrative expenses	(447,490)	(57,300)	(2,104,260)	(295,183)
Total operating expenses	(485,355)	(102,621)	(2,224,567)	(397,385)
OTHER EXPENSE:
Loss on sale of marketable securities	(251)		(27,869)
Total other expense	(485,606)		(27,869)
Net (Loss)	(485,606)	(102,621)	(2,252,436)	(397,385)
Provision for income taxes
Net loss	(485,606)	(102,621)	(2,252,436)	(397,385)
Less: loss attributable to non-controlling Interest	21,462	6,685	58,554	21,872
Net loss attributable to Canna Powder, Inc.	$ (464,144)	$ (95,936)	$ (2,193,882)	$ (375,513)
Loss per share - basic and diluted	$ (0.04)	$ (0.01)	$ (0.19)	$ (0.04)
Weighted average shares outstanding Basic and diluted	12,301,559	9,948,077	11,737,185	9,372,940

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Comprehensive Income [Abstract]
Net loss	$ (485,606)	$ (102,621)	$ (2,252,436)	$ (397,385)
Less: Non-controlling interest	21,462	6,685	58,554	21,872
Total (loss) attributable to Canna Powder, Inc. ordinary shareholders.	(464,144)	(95,936)	(2,193,882)	(375,513)
Other comprehensives (loss) income:
-Foreign currency translation	5,990	(874)	12,802	(8,023)
-Unrealized holding gains (losses)			138,499
-Reclassification adjustments for realized losses (gains) on marketable securities.			27,869
Net loss comprehensive (loss) attributable to Canna Powder, Inc. ordinary shareholders.	$ (458,154)	$ (97,810)	$ (2,015,712)	$ (383,536)

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Stock Payable [Member]	Non-Controlling Interest [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2017	$ 86	$ 447,164			$ 3,353	$ (123,164)	$ 327,439
Balance, shares at Dec. 31, 2017	8,591,577
Shares Issued for Cash	$ 13	813,887					813,900
Shares Issued for Cash, shares	1,356,500
Translation adjustments					(8,023)		(8,023)
Net loss				(21,872)		(375,513)	(397,385)
Balance at Sep. 30, 2018	$ 99	1,261,051		(21,872)	(4,670)	(498,677)	735,931
Balance, shares at Sep. 30, 2018	9,948,077
Balance at Jun. 30, 2018	$ 99	1,261,051		(15,187)	(3,794)	(402,741)	839,428
Balance, shares at Jun. 30, 2018	9,948,077
Translation adjustments					(876)		(876)
Net loss				(6,685)		(95,936)	(102,621)
Balance at Sep. 30, 2018	$ 99	1,261,051		(21,872)	(4,670)	(498,677)	735,931
Balance, shares at Sep. 30, 2018	9,948,077
Balance at Dec. 31, 2018	$ 105	4,472,095	15,000	(37,893)	(173,832)	(3,573,378)	702,097
Balance, shares at Dec. 31, 2018	10,518,226
Shares Issued for Cash	$ 3	333,997					334,000
Shares Issued for Cash, shares	334,000
Cashless exercise of warrants	$ 16	(16)
Cashless exercise of warrants, shares	1,538,326
Warrants issued for services		1,123,280					1,123,280
Stock payable issued		15,000	(15,000)
Stock payable issued, shares	12,500
Translation adjustments					12,802		13,852
Realized loss on marketable securities					166,368		165,318
Net loss				(58,554)		(2,193,882)	(2,252,436)
Balance at Sep. 30, 2019	$ 124	5,944,356		(96,447)	5,338	(5,767,260)	86,111
Balance, shares at Sep. 30, 2019	12,403,052
Balance at Jun. 30, 2019	$ 120	5,832,996		(74,985)	(650)	(5,303,116)	454,365
Balance, shares at Jun. 30, 2019	12,156,177
Cashless exercise of warrants	$ 3	(3)
Cashless exercise of warrants, shares	246,875
Warrants issued for services		111,363					111,363
Translation adjustments					5,988		5,988
Net loss				(21,462)		(464,144)	(485,606)
Balance at Sep. 30, 2019	$ 124	$ 5,944,356		$ (96,447)	$ 5,338	$ (5,767,260)	$ 86,111
Balance, shares at Sep. 30, 2019	12,403,052

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Operating Activities:
Net (loss) attributable to Canna Powder, Inc.	$ (464,144)	$ (95,936)	$ (2,193,882)	$ (375,513)
Non -controlling interest in loss of consolidated subsidiary	(21,462)	(6,685)	(58,554)	(21,872)
Non-cash compensation			1,123,281
Loss on sale of marketable securities	251		27,869
Changes in net assets and liabilities:
Decrease (increase) in prepaid expenses			8,141	(10,321)
(Decrease) increase in Accounts payable and accrued liabilities			(25,159)	(800)
Net Cash (used in) operating activities			(1,118,304)	(408,506)
Investing Activities:
Cash received for sale of marketable securities			234,112
Net Cash provided by investing activities			234,112
Financing Activities:
Principal payment on debt				(2,687)
Proceeds from sale of common stock (net of issuance expenses)			334,000	813,900
Net Cash provided by financing activities			334,000	811,213
Effect of currency on cash			12,802	(8,023)
Net increase (decrease) in cash			(537,390)	394,684
Cash and cash equivalents - beginning of period			606,245	326,730
Cash and cash equivalents - end of period	$ 68,855	$ 721,414	68,855	721,414
Non Cash items:
Common shares issued from stock payable			15,000
Cashless exercise of warrants			$ 16

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	(1) Summary of Significant Accounting Policies Basis of Presentation and Organization The Company was incorporated in 1999 in the state of Utah under the name Datigen.com, Inc. On August 25, 2005, the Company changed its state of incorporation from Utah to Nevada by the merger of the Company with and into its wholly-owned subsidiary, Canna Powder, Inc., a Nevada corporation. As a result of such merger, the Company’s name was changed to Canna Powder, Inc. in order to better reflect the Company’s business operations. On August 30, 2017, a new wholly-owned subsidiary was registered in Israel under the name of Canna Powder Ltd. (“CannaPowder Israel” or the “Subsidiary”), with 100 common shares outstanding, 0.01 NIS par value (the “Subsidiary Shares”), all of which were held in escrow on behalf of the Company by Israel attorney, Alon Nave. On September 27, 2017, pursuant to board resolution, the 100 Subsidiary Shares held in escrow were transferred to the Company. On December 27, 2017, a board-resolution was adopted to issue an additional: (i) 800 Subsidiary Shares to the Company; and an additional 100 Subsidiary Shares to Rafi Ezra and, as a result, effective December 27, 2017, Canna Powder Ltd became a 90% owned subsidiary of the Company and a minority interest of 10% owned by Rafi Ezra. The Subsidiary’s management consists of Ariel Dor, its General Manger, and Rafi Ezra, its CTO. Research is being conducted at the Hebrew University pursuant to the terms of a Feasibility Study and Option Agreement under the supervision of the inventor of the technology, Professor Shlomo Magdassi (the “Development Program”). The Company currently expects that the Development Program will be completed within three years from its start, with commercial sales starting in 2021. However, there can be no assurance that the Development Program will, in fact, be successful, nor can there be any assurance that the Company may not require additional capital to fully implement its business plan and complete production of commercially viable products based on its technology which is the subject of the Feasibility Study discussed below under “Planned Research and Development and Current Trends.” In the commercial stage, the Company’s plan is to establish and operate several production facilities, each located in separate territories determined by the Company according to their size and regulatory environment that permits studies applicable to other activities prerequisite to commercial exploitation of medical cannabis generally and the Company’s plan to develop cannabis-based powders for medical uses. While there can be no assurance, at present the Company believes that it will be able to produce cannabis powders for medical uses at a significant cost advantage. The accompanying unaudited condensed consolidated financial statements of the Company are presented in accordance with the requirements of Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for an air presentation have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2018 and the notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2019. Cash and Cash Equivalents For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of September 30, 2019, and December 31, 2018, we had cash and cash equivalents of $68,855 and $606,245 respectively. Reclassifications Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows. Revenue Recognition The Company recognizes revenue ratably over the term of the contract in accordance with ASC 606. In 2018, we implemented new internal controls as part of our efforts to adopt the new revenue recognition standard and perform risk assessment processes related to the new revenue standard. These internal controls include providing global training to our finance team and holding regular meetings with management to address risks associated with applying the five-step model for recognizing revenues. Additionally, we established monitoring controls to identify new sales arrangements and changes in our business environment that could impact risks associated with the new revenue standard and our current accounting assessment process. Loss per Common Share Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential shares of common stock had been issued and if the additional shares of common stock were dilutive. Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carryforward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the period of the change in estimate. Fair Value of Financial Instruments The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts the Company could realize in a current market exchange. As of September 30, 2019 and December 31 2018, the carrying value of accounts payable and accrued liabilities approximated fair value due to the short-term nature and maturity of these instruments. Deferred Offering Costs The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated. Impairment of Long-Lived Assets The Company evaluates the recoverability of long-lived assets and the related estimated remaining lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable. As of September 30, 2019 and December 31, 2018, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required. Use of Estimates The financial statements are prepared on the basis of US GAAP. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the financial statements, and the reported expenses during the reporting period. Actual results could differ from those estimates made by management. There are no leases in the Company, thus the financial statements do not include estimates to recognize assets and liabilities related to implementing the new leases standard ASC 842. Impact of Recently Issued Accounting Standards On December 15, 2018 the Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) 2016-02, Leases (Topic 842) issued on February 25, 2016 became effective. Under the new provisions, all lessees will report a right-of-use asset and a liability for the obligation to make payments for all leases with the exception of those leases with a term of 12 months or less. All other leases will fall into one of two categories: Financing leases, similar to capital leases, will require the recognition of an asset and liability, measured at the present value of the lease payments or Interest on the liability will be recognized separately from amortization of the asset. Principal repayments will be classified as financing outflows and payments of interest as operating outflows on the statement of cash flows. Operating leases will also require the recognition of an asset and liability measured at the present value of the lease payments. A single lease cost, consisting of interest on the obligation and amortization of the asset, calculated such that the amortization of the asset will increase as the interest amount decreases resulting in a straight-line recognition of lease expense. All cash outflows have been classified as operating on the statement of cash flows. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement. In June 2018, the FASB issued Accounting Standards Update, or ASU 2018-07, Compensation - Stock Compensation (Topic 718), which simplifies the accounting for non-employee share-based payment transactions. The new standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018 (including interim periods within that fiscal year), with early adoption permitted. The Company adopted the new standard in the second quarter of 2018 and the new standard is applied share-based payment transactions as reflected in the Company’s unaudited condensed consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. Public business entities should apply the amendments in this Update to annual periods beginning after December 15, 2017, including interim periods within those periods. All other entities should apply the amendments to annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. In March 2017, the FASB issued Update 2017-08—Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, including adoption in an interim period. The Company adopted the new standard and the new standard is reflected in the Company’s unaudited condensed consolidated financial statements. In March 2017, the FASB issued Update 2017-07—Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. Effective for public business entities for annual periods beginning after December 15, 2017, including interim periods within those annual periods. For other entities, the amendments in this Update are effective for annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or made available for issuance. The Company adopted the new standard and the new standard is reflected in the Company’s unaudited condensed consolidated financial statements.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note (2) Going Concern The Company has limited operations its current deficit amount is $5,767,260 as of September 30, 2019. The accompanying financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern. The Company has not yet generated any revenue to cover its operating costs, and as such, has incurred an operating loss since inception. These negative cash flows from operations, limited business operations and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Prepaid Expenses

Prepaid Expenses	9 Months Ended
	Sep. 30, 2019
Prepaid Expenses
Prepaid Expenses	Note (3) Prepaid expenses Prepaid expenses of $17,256 at September 30, 2019 and $12,847 at December 31, 2018, consist of tax whithld at asource by VAT paid to be refunded from the Israel VAT authority and income tax withheld related to sale of marketable securities.

Common Stock

Common Stock	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Common Stock	Note (4) Common Stock Between March 20, 2018 and March 29, 2018, the Company sold a total of 206,000 units for cash consideration of $123,600 at a price of $.60 per share, each unit was comprised of one share of common stock and one class B warrant exercisable at $1.20 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $44,454 for the common stock and $79,146 for the class B Warrants. Between April 3, 2018 and May 14, 2018, the Company sold a total of 1,150,500 units for cash consideration of $690,300 at a price of $.60 per share, each unit was comprised of one share of common stock and one class B warrant exercisable at $1.20 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $290,996 for the common stock and $399,304 for the class B Warrants. Between October 18, 2018 and October 22, 2018, the Company sold a total of 345,166 units for cash consideration of $207,004 at a price of $.60 per share, each unit was comprised of one share of common stock and one class B warrant exercisable at $1.20 per share with a term of 24 months. The relative fair value of the stock with embedded warrants was $64,431 for the common stock and $142,573 for the class B Warrants. Between November 5, 2018 and November 28, 2018, the Company sold a total of 187,483 units for cash consideration of $224,980 at a price of $1.20 per share, each unit was comprised of one share of common stock and one class D warrant exercisable at $2.40 per share with a term of 24 months. Of these shares, 12,500 shares were recorded as subscribed share capital. The relative fair value of the stock with embedded warrants was $70,026 for the common stock and $154,954 for the class B Warrants During the year ended December 31, 2018 50,000 shares were issued to one officer for services provided to the Company. Such shares were valued at $26,000. On May 1, 2018, one consultant was issued a two-year Class B Warrants to acquire an aggregate of 41,000 shares of common stock at an exercise price of $1.20 per share. The fair value of these warrants is $26,731. The warrants were valued using the Black-Scholes model with volatility of 139% and discount rate of 2.50%. The Class B warrants are fully vested and were accordingly included in expenses as stock based compensation. On December 10, 2018, three consultants were issued 750,000 Class J Warrants exercisable for a three-year period to acquire one share of common stock at a price of $0.30 per share; The fair value of these warrants is $1,199,643. The warrants were valued using the Black-Scholes model with volatility of 390% and discount rate of 2.73%. The Class J warrants are fully vested and were accordingly included in expenses as stock based compensation. On December 10, 2018, three consultants were issued 450,000 Class I Warrants exercisable for a two-year period to acquire one share of common stock at a price of $0.01 per share; The fair value of these warrants is $719,774. The warrants were valued using the Black-Scholes model with volatility of 390% and discount rate of 2.72%. The Class I warrants are fully vested and were accordingly included in expenses as stock based compensation. On November 1, 2018, two consultants were issued 200,000 Class E Warrants exercisable for a four-year period to acquire one share of common stock at a price of $0.01 per share; The fair value of these warrants are $ 249,998. The warrants were valued using the Black-Scholes model with volatility of 388% and discount rate of 2.94%. The Class E warrants are fully vested and were accordingly included in expenses as stock based compensation. On November 1, 2018, one consultant was issued 100,000 Class F Warrants exercisable for a five-year period to acquire one share of common stock at a price of $3.00 per share; The fair value of these warrants is $124,997. The warrants were valued using the Black-Scholes model with volatility of 388% and discount rate of 2.96%. The Class F warrants are fully vested and were accordingly included in expenses as stock based compensation. On November 1, 2018, one consultant was issued 200,000 Class G Warrants exercisable for a five-year period to acquire one share of common stock at a price of $5.00 per share; The fair value of these warrants is $249,994. The warrants were valued using the Black-Scholes model with volatility of 388% and discount rate of 2.96%. The Class G warrants are fully vested and were accordingly included in expenses as stock based compensation. On November 1, 2018, one consultant was issued 100,000 Class H Warrants exercisable for a five-year period to acquire one share of common stock at a price of $1.00 per share; The fair value of these warrants is $124,999. The warrants were valued using the Black-Scholes model with volatility of 388% and discount rate of 2.96%. The Class H warrants are fully vested and were accordingly included in expenses as stock based compensation. On December 12, 2018, one consultant was issued 50,000 Class C Warrants exercisable for a four-year period to acquire one share of common stock at a price of $2.40 per share; The fair value of these warrants is $62,492. The warrants were valued using the Black-Scholes model with volatility of 388% and discount rate of 2.94%. On December 12, 2018, one consultant was issued 75,000 Class E Warrants exercisable for a five-year period to acquire one share of common stock at a price of $0.01 per share. The warrants are vesting equally over eight quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $9,439 in 2018 plus $24,311 in Q1 and Q2 2019 out of $89,999 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.22%. On January 1, 2019, the Company issued an officer in consideration for services 300,000 Class I Warrants exercisable for a period of two years at an exercise price of $.01 per share. The warrants vest one third immediately, one third on December 31, 2019 and one third on December 31, 2020. The fair value of the vested amount recorded as expense as of September 30, 2019 was $159,341 out of $229,957 total value. The warrants were valued using the Black-Scholes model with volatility of 394% and discount rate of 2.47%. On May 7, 2019, due to the resignation of Liron Carmel as Chief Executive Officer and a director, 200,000 Class J Warrants exercisable for a period of three years at an exercise price of $.30 per share were forfeited. On January 24, 2019, the Company sold a total of 334,000 units for cash consideration of $334,000 at price of $1.00, each unit was comprised of one share of common stock, one Class F warrant exercisable at $3.00 per share with a term of 36 months and one Class G warrant exercisable at $5.00 per share with a term of 60 months. The relative fair value of the stock with embedded warrants was $73,513 for the common stock and $260,187 for the class F and class G Warrants. On January 27, 2019, 12,500 shares subscribed for in 2018 and recorded as stock payable were issued to a shareholder who the Company sold common stock to on November 21, 2018 and recorded subscribed share capital for during the period ending December 31, 2018. On January 31, 2019, one consultant was issued 50,000 Class E Warrants exercisable for a four-year period to acquire one share of common stock at a price of $0.01 per share; The fair value of these warrants are $94,999. The warrants were valued using the Black-Scholes model with volatility of 390% and discount rate of 2.43%. The Class E warrants are fully vested and were accordingly included in expenses as stock based compensation. On February 28, 2019, one officer converted 100,000 Class I Warrants to 99,576 shares of common stock in a cashless exercise. On April 5, 2019, one officer converted 100,000 Class J Warrants to 87,500 shares of common stock in a cashless exercise On April 5, 2019, three consultants converted an aggregate of 750,000 Class J Warrants to 656,250 shares of common stock in a cashless exercise. On April 5, 2019, three consultants converted an aggregate of 750,000 Class I Warrants to 448,125 shares of common stock in a cashless exercise. On May 1, 2019, Shai Cohen, Chairman and CEO, was issued 150,000 Class F Warrants exercisable for a three-year period to acquire one share of common stock at a price of $3.00 per share; The Class F warrants are vesting equally over twelve quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $27,476 out of $329,716 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.28%. On May 1, 2019, Shai Cohen, Chairman and CEO was issued 100,000 Class G Warrants exercisable for a five-year period to acquire one share of common stock at a price of $5.00 per share; The Class G warrants are vesting equally over twelve quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $36,661 out of $219,968 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.30%. On May 1, 2019, Shai Cohen, Chairman and CEO was issued 150,000 Class H Warrants exercisable for a five-year period to acquire one share of common stock at a price of $1.00 per share; The Class H warrants are vesting equally over twelve quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $54,996 out of $329,979 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.30%. On May 1, 2019, Shai Cohen, Chairman and CEO was issued 250,000 Class I Warrants exercisable for a two-year period to acquire one share of common stock at a price of $.01 per share; The Class I warrants are vesting equally over twelve quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $91,658 out of $549,945 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.28%. On May 1, 2019, Ariel Dor, General Manager of the Subsidiary was issued 250,000 Class I Warrants exercisable for a two-year period to acquire one share of common stock at a price of $.01 per share; The fair value of these warrants is $549,855. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.31%. The Class I warrants are fully vested and were accordingly included in expenses as stock based compensation. On June 1, 2019, one consultant was awarded 25,000 Class A Warrants exercisable for a two-year period to acquire one share of common stock at a price of $.50 per share for service provided to the Company. The fair value of the vested amount recorded as expense as of September 30, 2019 was $49,857. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 1.82%. On June 25, 2019 one consultant was awarded 17,000 Class I Warrants exercisable for a two-year period to acquire one share of common stock at a price of $.01 per share for services provided to the Company. The fair value of the vested amount recorded as expense as of September 30, 2019 was $23,792. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 1.71%. Following is a table of warrant and options outstanding as of September 30, 2019 and exercisable along with the exercise price and range of remaining term. Type Quantity Exercise Price Expiration Date Warrants Class A 825,000 $ 0.50 12 Months Warrants Class B 1,599,166 $ 1.20 12-18 Months Warrants Class C 50,000 $ 2.4 48 Months Warrants Class D 330,983 $ 2.4 8 Months Warrants Class E 325,000 $ 0.01 48 Months Warrants Class F 584,000 $ 3.00 36 Months Warrants Class G 634,000 $ 5.00 60 Months Warrants Class H 250,000 $ 1.00 60 Months Warrants Class I 467,000 $ 0.01 24 Months Total 5,065,149 On September 30, 2019 and December 31, 2018 there were approximately 227 and 226 holders of record and 12,403,052 and 10,518,226 shares of the Company’s common stock par value $0.00001 per share, outstanding, respectively. All shares of common stock are entitled to one vote per share in all matters submitted to the shareholders. No preferred shares were issued and outstanding at September 30, 2019 and December 31, 2018. Dividends The Company has not declared or paid any cash dividends on its common stock nor does it anticipate paying any in the foreseeable future. Furthermore, the Company expects to retain any future earnings to finance its operations and expansion. The payment of cash dividends in the future will be at the discretion of its Board of Directors and will depend upon its earnings levels, capital requirements, any restrictive loan covenants and other factors the Board considers relevant. Securities Authorized for Issuance under Equity Compensation Plans – None.

Marketable Securities

Marketable Securities	9 Months Ended
	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Note (5) Marketable Securities Marketable Securities of $0 at September 30, 2019 and $108,164 at December 31, 2018 consist of 200,000 shares of UNV Medicine Ltd. a public company organized under the laws of Israel (“UNV”). CannaPowder Israel paid $274,531 to UNV for the Marketable Securities for which in return UNV will finance and purchase a line of equipment to be used for the production of certain products, based on CannaPowder Israel’s specifications. On April 24, 2019 CannaPowder Israel sold the 200,000 UNV shares for $234,112 and recorded a realized loss on marketable securities of $27,618. As of December 31, 2018, CannaPowder Israel’s Statements of Operations included a $166,010 unrealized loss from Marketable Securities which as of the date of the sale, April 24, 2019, were reclassified and included in the $27,869 realized loss on marketable securities.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Note (6) Income Taxes The provision (benefit) for income taxes for the periods ended September 30, 2019 and December 31, 2018, was as follows (assuming a 21% effective tax rate in 2019 and 21% in 2018): September 30, 2019 December 31, 2018 Current tax provision: Federal- Taxable income $ - $ - Total current tax provision $ - $ - The Company had deferred income tax assets as of September 30, 2019 and December 31, 2018 as follows: September 30, 2019 December 31, 2018 Loss carryforwards $ 1,211,125 $ 750,409 Less- Valuation allowance (1,211,125 ) (750,409 ) Total net deferred tax assets $ - $ - The Company provided a valuation allowance equal to the deferred income tax assets for the period ended September 30, 2019 and December 31, 2018, because it is not presently known whether future taxable income will be sufficient to utilize the loss carryforwards. As of September 30, 2019, and December 31, 2018, the Company had approximately $1,729,738 and $123,164, respectively, in tax loss carryforwards that can be utilized in future periods to reduce taxable income and which expire by the year 2030. The Company did not identify any material uncertain tax positions that will be filed. The Company did not recognize any interest or penalties for unrecognized tax benefits during the three months ended September 30, 2019 or the year ended December 31, 2018. The Company intends to file income tax returns in the United States. All tax years are closed by expiration of the statute of limitations.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	Note (7) Related Party Transactions On January 31, 2019, One of a kind marketing DUSA LLC, a Texas limited liability company (“Dusa”) was issued 50,000 Class E Warrants exercisable for a four-year period to acquire one share of common stock at a price of $0.01 per share; The fair value of these warrants are $94,999. The warrants were valued using the Black-Scholes model with volatility of 390% and discount rate of 2.43%. The Class E warrants are fully vested and were accordingly included in expenses as stock based compensation. On May 1, 2019, the Subsidiary entered into a service agreement (the “Dusa Service Agreement”) with One of a kind marketing DUSA LLC, to provide international business development and strategic marketing services to the Subsidiary. The term of the Agreement commenced on May 1, 2019 and will continue as long as the Company continues its operations and progress in fulfilling its goals unless sooner terminated in accordance with the Agreement. As compensation therefor, Dusa will be entitled to monthly fee of $15,000. The Subsidiary and Dusa may terminate the Dusa Service Agreement at any time upon 30 days prior written notice. On May 1, 2019, the Company, entered into a service agreement with Shai Cohen Chairman and CEO pursuant to which Mr. Cohen will serve as chief executive officer and chairman of the board of the Company. The term of the Cohen Service Agreement commenced on May 1, 2019 and will continue as long as the Company continues its operations and progress in fulfilling its goals unless sooner terminated in accordance with the Agreement. As compensation therefor, Mr. Cohen received the following warrants: (i) 150,000 Class F Warrants exercisable for a three-year period to acquire one share of common stock at a price of $3.00 per share; The Class F warrants are vesting equally over twelve quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $27,476 out of $329,716 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.28%. (ii) 100,000 Class G Warrants exercisable for a five-year period to acquire one share of common stock at a price of $5.00 per share; The Class G warrants are vesting equally over twelve quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $18,331 out of $219,968 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.30%. (iii) 150,000 Class H Warrants exercisable for a five-year period to acquire one share of common stock at a price of $1.00 per share; The Class H warrants are vesting equally over twelve quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $27,498 out of $329,979 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.30%. (iv) 250,000 Class I Warrants exercisable for a two-year period to acquire one share of common stock at a price of $.01 per share; The Class I warrants are vesting equally over twelve quarters, thus the fair value of the vested amount recorded as expense as of September 30, 2019 was $45,829 out of $549,945 total value. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.28%. On May 1, 2019, Ariel Dor, General Manager of the Subsidiary was issued 250,000 Class I Warrants exercisable for a two-year period to acquire one share of common stock at a price of $.01 per share; The fair value of these warrants is $549,855. The warrants were valued using the Black-Scholes model with volatility of 389% and discount rate of 2.31%. The Class I warrants are fully vested and were accordingly included in expenses as stock based compensation. On May 7, 2019 Liron Carmel resigned as the Company’s Chief Executive Officer and director and Shai Cohen, a more than 10% shareholder was appointed as the Company’s Chief Executive Officer and director. On April 18, 2019, a group of persons and entities owning shares in the Company, sold an aggregate of 500,000 shares of common stock to One of a Kind Kamami LLC, and 5,500,000 shares of common stock to MNSCO LLC, entities which are more than 10% owned by Shai Cohen. On January 1, 2019, the Company issued one officer in consideration for services 300,000 Class I Warrants exercisable for a period of three years at an exercise price of $.01 per share and 300,000 Class J Warrants exercisable for a period of three years at an exercise price of $.30 per share. The warrants vest one third immediately, one third on December 31, 2019 and one third on December 31, 2020. The fair value of the vested amount recorded as expense as of September 30, 2019 was $149,966 out of $449,898 total value. The warrants were valued using the Black-Scholes model with volatility of 394% and discount rate of 2.47%. On February 28, 2019, 100,000 Class I warrants were converted to 99,576 common shares in a cashless exercise. On December 10, 2018, three entities were issued an aggregate of 750,000 Class J Warrants exercisable for a three-year period to acquire one share of common stock at a price of $0.30 per share for consulting services provided to the company; The fair value of these warrants is $1,199,643. The warrants were valued using the Black-Scholes model with volatility of 390% and discount rate of 2.73%. The Class J warrants are fully vested and were accordingly included in expenses as stock based compensation. The entities are considered related parties as they are more than 5% shareholders or are controlled by individuals who are more than 5% shareholders. On December 10, 2018, three entities, were issued an aggregate of 450,000 Class I Warrants exercisable for a two-year period to acquire one share of common stock at a price of $0.01 per share for consulting services provided to the company; The fair value of these warrants is $719,774. The warrants were valued using the Black-Scholes model with volatility of 390% and discount rate of 2.72%. The Class I warrants are fully vested and were accordingly included in expenses as stock based compensation. The entities are considered related parties as they are more than 5% or are controlled by individuals who are more than 5% shareholders. On October 17, 2017, Amir Uziel, Attribute Ltd, Lavi Krasney and Kfir Silberman (controlling shareholder of L.I.A. Pure Capital Ltd.) each purchased 650,000 shares of common stock at $0.01 per share for a total cash consideration of $26,000.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2019
Subsequent Events [Abstract]
Subsequent Events	Note (8) Subsequent Events As defined in FASB ASC 855-10, “Subsequent Events”, subsequent events are events or transactions that occur after the balance sheet date but before financial statements are issued or available to be issued. The Company evaluated all transactions and events that occurred subsequent to the balance sheet date and prior to the date on which the financial statements contained in this report were issued and determined that no such events or transactions necessitated disclosure.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Basis of Presentation and Organization	(1) Summary of Significant Accounting Policies Basis of Presentation and Organization The Company was incorporated in 1999 in the state of Utah under the name Datigen.com, Inc. On August 25, 2005, the Company changed its state of incorporation from Utah to Nevada by the merger of the Company with and into its wholly-owned subsidiary, Canna Powder, Inc., a Nevada corporation. As a result of such merger, the Company’s name was changed to Canna Powder, Inc. in order to better reflect the Company’s business operations. On August 30, 2017, a new wholly-owned subsidiary was registered in Israel under the name of Canna Powder Ltd. (“CannaPowder Israel” or the “Subsidiary”), with 100 common shares outstanding, 0.01 NIS par value (the “Subsidiary Shares”), all of which were held in escrow on behalf of the Company by Israel attorney, Alon Nave. On September 27, 2017, pursuant to board resolution, the 100 Subsidiary Shares held in escrow were transferred to the Company. On December 27, 2017, a board-resolution was adopted to issue an additional: (i) 800 Subsidiary Shares to the Company; and an additional 100 Subsidiary Shares to Rafi Ezra and, as a result, effective December 27, 2017, Canna Powder Ltd became a 90% owned subsidiary of the Company and a minority interest of 10% owned by Rafi Ezra. The Subsidiary’s management consists of Ariel Dor, its General Manger, and Rafi Ezra, its CTO. Research is being conducted at the Hebrew University pursuant to the terms of a Feasibility Study and Option Agreement under the supervision of the inventor of the technology, Professor Shlomo Magdassi (the “Development Program”). The Company currently expects that the Development Program will be completed within three years from its start, with commercial sales starting in 2021. However, there can be no assurance that the Development Program will, in fact, be successful, nor can there be any assurance that the Company may not require additional capital to fully implement its business plan and complete production of commercially viable products based on its technology which is the subject of the Feasibility Study discussed below under “Planned Research and Development and Current Trends.” In the commercial stage, the Company’s plan is to establish and operate several production facilities, each located in separate territories determined by the Company according to their size and regulatory environment that permits studies applicable to other activities prerequisite to commercial exploitation of medical cannabis generally and the Company’s plan to develop cannabis-based powders for medical uses. While there can be no assurance, at present the Company believes that it will be able to produce cannabis powders for medical uses at a significant cost advantage. The accompanying unaudited condensed consolidated financial statements of the Company are presented in accordance with the requirements of Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for an air presentation have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2018 and the notes thereto included in the Company’s Annual Report on Form 10-K filed with the SEC on April 1, 2019.
Cash and Cash Equivalents	Cash and Cash Equivalents For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents. As of September 30, 2019, and December 31, 2018, we had cash and cash equivalents of $68,855 and $606,245 respectively.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings, financial position or cash flows.
Revenue Recognition	Revenue Recognition The Company recognizes revenue ratably over the term of the contract in accordance with ASC 606. In 2018, we implemented new internal controls as part of our efforts to adopt the new revenue recognition standard and perform risk assessment processes related to the new revenue standard. These internal controls include providing global training to our finance team and holding regular meetings with management to address risks associated with applying the five-step model for recognizing revenues. Additionally, we established monitoring controls to identify new sales arrangements and changes in our business environment that could impact risks associated with the new revenue standard and our current accounting assessment process.
Loss Per Common Share	Loss per Common Share Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the potential shares of common stock had been issued and if the additional shares of common stock were dilutive.
Income Taxes	Income Taxes Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carryforward period under the Federal tax laws. Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the period of the change in estimate.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts the Company could realize in a current market exchange. As of September 30, 2019 and December 31 2018, the carrying value of accounts payable and accrued liabilities approximated fair value due to the short-term nature and maturity of these instruments.
Deferred Offering Costs	Deferred Offering Costs The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company evaluates the recoverability of long-lived assets and the related estimated remaining lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable. As of September 30, 2019 and December 31, 2018, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.
Use of Estimates	Use of Estimates The financial statements are prepared on the basis of US GAAP. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the financial statements, and the reported expenses during the reporting period. Actual results could differ from those estimates made by management. There are no leases in the Company, thus the financial statements do not include estimates to recognize assets and liabilities related to implementing the new leases standard ASC 842.
Impact of Recently Issued Accounting Standards	Impact of Recently Issued Accounting Standards On December 15, 2018 the Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) 2016-02, Leases (Topic 842) issued on February 25, 2016 became effective. Under the new provisions, all lessees will report a right-of-use asset and a liability for the obligation to make payments for all leases with the exception of those leases with a term of 12 months or less. All other leases will fall into one of two categories: Financing leases, similar to capital leases, will require the recognition of an asset and liability, measured at the present value of the lease payments or Interest on the liability will be recognized separately from amortization of the asset. Principal repayments will be classified as financing outflows and payments of interest as operating outflows on the statement of cash flows. Operating leases will also require the recognition of an asset and liability measured at the present value of the lease payments. A single lease cost, consisting of interest on the obligation and amortization of the asset, calculated such that the amortization of the asset will increase as the interest amount decreases resulting in a straight-line recognition of lease expense. All cash outflows have been classified as operating on the statement of cash flows. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement. In June 2018, the FASB issued Accounting Standards Update, or ASU 2018-07, Compensation - Stock Compensation (Topic 718), which simplifies the accounting for non-employee share-based payment transactions. The new standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. ASU 2018-07 is effective for fiscal years beginning after December 15, 2018 (including interim periods within that fiscal year), with early adoption permitted. The Company adopted the new standard in the second quarter of 2018 and the new standard is applied share-based payment transactions as reflected in the Company’s unaudited condensed consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. Public business entities should apply the amendments in this Update to annual periods beginning after December 15, 2017, including interim periods within those periods. All other entities should apply the amendments to annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. In March 2017, the FASB issued Update 2017-08—Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, including adoption in an interim period. The Company adopted the new standard and the new standard is reflected in the Company’s unaudited condensed consolidated financial statements. In March 2017, the FASB issued Update 2017-07—Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. Effective for public business entities for annual periods beginning after December 15, 2017, including interim periods within those annual periods. For other entities, the amendments in this Update are effective for annual periods beginning after December 15, 2018, and interim periods within annual periods beginning after December 15, 2019. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or made available for issuance. The Company adopted the new standard and the new standard is reflected in the Company’s unaudited condensed consolidated financial statements.

Common Stock (Tables)

Common Stock (Tables)	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Schedule of Warrant and Options Outstanding and Exercisable	Following is a table of warrant and options outstanding as of September 30, 2019 and exercisable along with the exercise price and range of remaining term. Type Quantity Exercise Price Expiration Date Warrants Class A 825,000 $ 0.50 12 Months Warrants Class B 1,599,166 $ 1.20 12-18 Months Warrants Class C 50,000 $ 2.4 48 Months Warrants Class D 330,983 $ 2.4 8 Months Warrants Class E 325,000 $ 0.01 48 Months Warrants Class F 584,000 $ 3.00 36 Months Warrants Class G 634,000 $ 5.00 60 Months Warrants Class H 250,000 $ 1.00 60 Months Warrants Class I 467,000 $ 0.01 24 Months Total 5,065,149

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Schedule of Provision (Benefit) for Income Taxes	The provision (benefit) for income taxes for the periods ended September 30, 2019 and December 31, 2018, was as follows (assuming a 21% effective tax rate in 2019 and 21% in 2018): September 30, 2019 December 31, 2018 Current tax provision: Federal- Taxable income $ - $ - Total current tax provision $ - $ -
Schedule of Deferred Income Tax Assets	The Company had deferred income tax assets as of September 30, 2019 and December 31, 2018 as follows: September 30, 2019 December 31, 2018 Loss carryforwards $ 1,211,125 $ 750,409 Less- Valuation allowance (1,211,125 ) (750,409 ) Total net deferred tax assets $ - $ -

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Dec. 27, 2017	Sep. 27, 2017	Sep. 30, 2019	Dec. 31, 2018	Aug. 30, 2017
Common stock, shares outstanding			12,403,052	10,518,226
Common stock, par value			$ 0.00001	$ 0.00001
Subsidiary shares	800
Owned subsidiary percentage	90.00%
Cash and cash equivalents			$ 68,855	$ 606,245
Minimum [Member]
Intangible assets estimated useful lives			2 years
Maximum [Member]
Intangible assets estimated useful lives			20 years
Rafi Ezra [Member]
Subsidiary shares	100
Owned subsidiary percentage	10.00%
CannaPowder Israel [Member]
Common stock, shares outstanding					100
Common stock, par value					$ 0.01
Subsidiary shares		100

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 5,767,260	$ 3,573,378

Prepaid Expenses (Details Narra

Prepaid Expenses (Details Narrative) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Prepaid Expenses
Prepaid expenses	$ 17,256	$ 12,847

Common Stock (Details Narrative

Common Stock (Details Narrative)

May 01, 2019USD ($)$ / sharesshares

Apr. 05, 2019shares

Feb. 28, 2019shares

Jan. 31, 2019USD ($)$ / sharesshares

Jan. 27, 2019shares

Jan. 24, 2019USD ($)$ / sharesshares

Dec. 12, 2018USD ($)$ / sharesshares

Dec. 10, 2018USD ($)$ / sharesshares

Nov. 01, 2018USD ($)$ / sharesshares

Oct. 22, 2018USD ($)$ / sharesshares

Mar. 29, 2018USD ($)$ / sharesshares

Nov. 28, 2018USD ($)$ / sharesshares

May 14, 2018USD ($)$ / sharesshares

Sep. 30, 2019USD ($)$ / sharesshares

Sep. 30, 2018shares

Dec. 31, 2018USD ($)$ / sharesshares

Jun. 30, 2019USD ($)

Jun. 25, 2019$ / sharesshares

Jun. 01, 2019$ / sharesshares

May 07, 2019$ / sharesshares

Mar. 31, 2019USD ($)

Jan. 02, 2019USD ($)$ / sharesshares

May 01, 2018$ / sharesshares

Number of shares sold

334,000

345,166

206,000

187,483

1,150,500

Total cash consideration | $

$ 334,000

$ 207,004

$ 123,600

$ 224,980

$ 690,300

Sale of stock price per share | $ / shares

$ 1

$ 0.60

$ 0.60

$ 1.20

$ 0.60

Number of shares called by each warrants

1

1

1

1

1

Fair value of warrants | $

$ 64,431

$ 44,454

$ 70,026

$ 290,996

Subscribed share capital

12,500

Common stock shares outstanding

12,403,052

10,518,226

Common stock par value | $ / shares

$ 0.00001

$ 0.00001

Common stock voting rights

All common shares are entitled to one vote per share in all matters submitted to the shareholders.

227 Holders [Member]

Common stock shares outstanding

12,403,052

Common stock par value | $ / shares

$ 0.00001

Preferred stock shares issued

Preferred stock shares outstanding

226 Holders [Member]

Common stock shares outstanding

10,518,226

Common stock par value | $ / shares

$ 0.00001

Preferred stock shares issued

Preferred stock shares outstanding

One Officer [Member]

Stock issued during period for services, shares

50,000

Stock issued during period for services, value | $

$ 26,000

Shareholder [Member]

Stock issued during period, shares

12,500

Class B Warrant [Member]

Number of shares called by each warrants

1

1

1

Warrants exercise price per share | $ / shares

$ 1.20

$ 1.20

$ 1.20

$ 1.20

Warrants term

24 months

24 months

24 months

Fair value of warrants | $

$ 142,573

$ 79,146

$ 154,954

$ 399,304

Class B Warrant [Member] | One Consultant [Member]

Warrants term

2 years

Fair value of warrants | $

$ 26,731

Number of warrants, exercisable

41,000

Share price | $ / shares

$ 1.20

Class B Warrant [Member] | One Consultant [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

139

Class B Warrant [Member] | One Consultant [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.50

Class D Warrant [Member]

Number of shares called by each warrants

1

Warrants exercise price per share | $ / shares

$ 2.40

2.4

Warrants term

24 months

Class J Warrant [Member] | One Officer [Member]

Warrants term

3 years

Number of warrants, exercisable

300,000

Share price | $ / shares

$ .30

Number of warrants converted

100,000

Number of converted stock

87,500

Class J Warrant [Member] | Three Consultants [Member]

Number of shares called by each warrants

1

Warrants term

3 years

Fair value of warrants | $

$ 1,199,643

Number of warrants, exercisable

750,000

Share price | $ / shares

$ 0.30

Class J Warrant [Member] | Three Consultants [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

390

Class J Warrant [Member] | Three Consultants [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.73

Class J Warrant [Member] | Chief Executive Officer and Director [Member]

Number of warrants, exercisable

200,000

Share price | $ / shares

$ .30

Class J Warrant [Member] | Three Consultants [Member]

Number of warrants converted

750,000

Number of converted stock

656,250

Class I Warrant [Member]

Warrants exercise price per share | $ / shares

$ 0.01

Number of converted stock

99,576

Class I Warrant [Member] | One Officer [Member]

Number of shares called by each warrants

100,000

Warrants term

3 years

Number of warrants, exercisable

300,000

Share price | $ / shares

$ 0.01

Number of warrants converted

100,000

Class I Warrant [Member] | One Consultant [Member]

Number of shares called by each warrants

1

Warrants term

2 years

Share price | $ / shares

$ .01

Number of warrants exercisable for services

17,000

Share-based payment award, options, vested in period, fair value | $

$ 23,792

Class I Warrant [Member] | One Consultant [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

389

Class I Warrant [Member] | One Consultant [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

1.71

Class I Warrant [Member] | Three Consultants [Member]

Number of shares called by each warrants

1

Warrants term

2 years

Fair value of warrants | $

$ 719,774

Number of warrants, exercisable

450,000

Share price | $ / shares

$ 0.01

Class I Warrant [Member] | Three Consultants [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

390

Class I Warrant [Member] | Three Consultants [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.72

Class I Warrant [Member] | Officer [Member]

Warrants term

2 years

Number of warrants, exercisable

300,000

Share price | $ / shares

$ 0.01

Fair value of warrants, vested | $

159,341

$ 229,957

Class I Warrant [Member] | Officer [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

394

Class I Warrant [Member] | Officer [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.47

Class I Warrant [Member] | Three Consultants [Member]

Number of warrants converted

750,000

Number of converted stock

448,125

Class I Warrant [Member] | Chairman and CEO [Member]

Number of shares called by each warrants

1

Warrants term

2 years

Number of warrants, exercisable

250,000

Share price | $ / shares

$ 0.01

Fair value of warrants, vested | $

$ 549,945

$ 91,658

Class I Warrant [Member] | Chairman and CEO [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

389

Class I Warrant [Member] | Chairman and CEO [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.28

Class I Warrant [Member] | General Manager [Member]

Number of shares called by each warrants

1

Warrants term

2 years

Fair value of warrants | $

$ 549,855

Number of warrants, exercisable

250,000

Share price | $ / shares

$ 0.01

Class I Warrant [Member] | General Manager [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

389

Class I Warrant [Member] | General Manager [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.31

Class E Warrant [Member]

Warrants exercise price per share | $ / shares

$ 0.01

Class E Warrant [Member] | One Consultant [Member]

Number of shares called by each warrants

1

1

Warrants term

4 years

5 years

Fair value of warrants | $

$ 94,999

Number of warrants, exercisable

50,000

75,000

Share price | $ / shares

$ 0.01

$ 0.01

Fair value of warrants, vested | $

$ 89,999

$ 24,311

$ 24,311

Class E Warrant [Member] | One Consultant [Member] | Eight Quarters [Member]

Fair value of warrants, vested | $

$ 9,439

Class E Warrant [Member] | One Consultant [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

390

389

Class E Warrant [Member] | One Consultant [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.43

2.22

Class E Warrant [Member] | Two Consultants [Member]

Number of shares called by each warrants

1

Warrants term

4 years

Fair value of warrants | $

$ 249,998

Number of warrants, exercisable

200,000

Share price | $ / shares

$ 0.01

Class E Warrant [Member] | Two Consultants [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

388

Class E Warrant [Member] | Two Consultants [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.94

Class F Warrant [Member]

Number of shares called by each warrants

1

Warrants exercise price per share | $ / shares

$ 3

$ 3

Warrants term

36 months

Class F Warrant [Member] | One Consultant [Member]

Number of shares called by each warrants

1

Warrants term

5 years

Fair value of warrants | $

$ 124,997

Number of warrants, exercisable

100,000

Share price | $ / shares

$ 3

Class F Warrant [Member] | One Consultant [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

388

Class F Warrant [Member] | One Consultant [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.96

Class F Warrant [Member] | Chairman and CEO [Member]

Number of shares called by each warrants

1

Warrants term

3 years

Number of warrants, exercisable

150,000

Share price | $ / shares

$ 3

Fair value of warrants, vested | $

$ 329,716

$ 27,476

Class F Warrant [Member] | Chairman and CEO [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

389

Class F Warrant [Member] | Chairman and CEO [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.28

Class G Warrant [Member]

Number of shares called by each warrants

1

Warrants exercise price per share | $ / shares

$ 5

$ 5

Warrants term

60 months

Class G Warrant [Member] | One Consultant [Member]

Number of shares called by each warrants

1

Warrants term

5 years

Fair value of warrants | $

$ 249,994

Number of warrants, exercisable

200,000

Share price | $ / shares

$ 5

Class G Warrant [Member] | One Consultant [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

388

Class G Warrant [Member] | One Consultant [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.96

Class G Warrant [Member] | Chairman and CEO [Member]

Number of shares called by each warrants

1

Warrants term

5 years

Number of warrants, exercisable

100,000

Share price | $ / shares

$ 5

Fair value of warrants, vested | $

$ 219,968

$ 36,661

Class G Warrant [Member] | Chairman and CEO [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

389

Class G Warrant [Member] | Chairman and CEO [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.30

Class H Warrant [Member]

Warrants exercise price per share | $ / shares

$ 1

Class H Warrant [Member] | One Consultant [Member]

Number of shares called by each warrants

1

Warrants term

5 years

Fair value of warrants | $

$ 124,999

Number of warrants, exercisable

100,000

Share price | $ / shares

$ 1

Class H Warrant [Member] | One Consultant [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

388

Class H Warrant [Member] | One Consultant [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.96

Class H Warrant [Member] | Chairman and CEO [Member]

Number of shares called by each warrants

1

Warrants term

5 years

Number of warrants, exercisable

150,000

Share price | $ / shares

$ 1

Fair value of warrants, vested | $

$ 329,979

$ 54,996

Class H Warrant [Member] | Chairman and CEO [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

389

Class H Warrant [Member] | Chairman and CEO [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.30

Class C Warrant [Member]

Warrants exercise price per share | $ / shares

$ 2.4

Class C Warrant [Member] | One Consultant [Member]

Number of shares called by each warrants

1

Warrants term

4 years

Fair value of warrants | $

$ 62,492

Number of warrants, exercisable

50,000

Share price | $ / shares

$ 2.40

Class C Warrant [Member] | One Consultant [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

388

Class C Warrant [Member] | One Consultant [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

2.94

Common Stock [Member]

Fair value of embedded warrants | $

$ 73,513

Stock issued during period, shares

334,000

1,356,500

Class F and G Warrant [Member]

Fair value of embedded warrants | $

$ 260,187

Class A Warrant [Member]

Warrants exercise price per share | $ / shares

$ 0.50

Class A Warrant [Member] | One Consultant [Member]

Number of shares called by each warrants

1

Warrants term

2 years

Share price | $ / shares

$ 0.50

Number of warrants exercisable for services

25,000

Share-based payment award, options, vested in period, fair value | $

$ 49,857

Class A Warrant [Member] | One Consultant [Member] | Volatility [Member]

Warrant fair value measurement input, percentage

389

Class A Warrant [Member] | One Consultant [Member] | Discount Rate [Member]

Warrant fair value measurement input, percentage

1.82

Common Stock - Schedule of Warr

Common Stock - Schedule of Warrant and Options Outstanding and Exercisable (Details) - $ / shares	9 Months Ended
	Sep. 30, 2019	Jan. 24, 2019	Nov. 28, 2018	Oct. 22, 2018	May 14, 2018	Mar. 29, 2018
Warrant Outstanding	5,065,149
Class A Warrant [Member]
Warrant Outstanding	825,000
Warrant Exercise Price	$ 0.50
Expiration Date	12 months
Class B Warrant [Member]
Warrant Outstanding	1,599,166
Warrant Exercise Price	$ 1.20			$ 1.20	$ 1.20	$ 1.20
Class B Warrant [Member] | Minimum [Member]
Expiration Date	12 months
Class B Warrant [Member] | Maximum [Member]
Expiration Date	18 months
Class C Warrant [Member]
Warrant Outstanding	50,000
Warrant Exercise Price	$ 2.4
Expiration Date	48 months
Class D Warrant [Member]
Warrant Outstanding	330,983
Warrant Exercise Price	$ 2.4		$ 2.40
Expiration Date	8 months
Class E Warrant [Member]
Warrant Outstanding	325,000
Warrant Exercise Price	$ 0.01
Expiration Date	48 months
Class F Warrant [Member]
Warrant Outstanding	584,000
Warrant Exercise Price	$ 3	$ 3
Expiration Date	36 months
Class G Warrant [Member]
Warrant Outstanding	634,000
Warrant Exercise Price	$ 5	$ 5
Expiration Date	60 months
Class H Warrant [Member]
Warrant Outstanding	250,000
Warrant Exercise Price	$ 1
Expiration Date	60 months
Class I Warrant [Member]
Warrant Outstanding	467,000
Warrant Exercise Price	$ 0.01
Expiration Date	24 months

Marketable Securities (Details

Marketable Securities (Details Narrative) - USD ($)	Apr. 24, 2019	Jan. 24, 2019	Oct. 22, 2018	Mar. 29, 2018	Nov. 28, 2018	May 14, 2018	Sep. 30, 2019	Dec. 31, 2018
Marketable securities								$ 108,164
Number of common stock sold		334,000	345,166	206,000	187,483	1,150,500
Number of common stock sold, amount		$ 334,000	$ 207,004	$ 123,600	$ 224,980	$ 690,300
Realized loss on marketable securities							$ 165,318
Unrealized loss on marketable securities	$ 27,618							$ 166,367
UNV Medicine Ltd [Member]
Marketable equity securities							200,000
Payments for marketable securities							$ 274,531
Number of common stock sold	200,000
Number of common stock sold, amount	$ 234,112
Realized loss on marketable securities	$ 27,869

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Operating loss carryforwards	$ 1,729,738	$ 123,164
Operating loss carryforwards expiration year	2030
Interest or penalties for unrecognized tax benefits

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provision (Benefit) for Income Taxes (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Current tax provision: Federal - Taxable income
Total current tax provision

Income Taxes - Schedule of Pr_2

Income Taxes - Schedule of Provision (Benefit) for Income Taxes (Details) (Parenthetical)	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Effective tax rate	21.00%	21.00%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Income Tax Assets (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Loss carryforwards	$ 1,211,125	$ 750,409
Less - Valuation allowance	(1,211,125)	(750,409)
Total net deferred tax assets

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	May 01, 2019USD ($)$ / sharesshares	Apr. 18, 2019shares	Apr. 05, 2019shares	Feb. 28, 2019shares	Jan. 31, 2019USD ($)$ / sharesshares	Jan. 24, 2019USD ($)$ / sharesshares	Jan. 02, 2019USD ($)$ / sharesshares	Dec. 10, 2018USD ($)$ / sharesshares	Dec. 10, 2018USD ($)$ / sharesshares	Oct. 22, 2018USD ($)$ / sharesshares	Mar. 29, 2018USD ($)$ / sharesshares	Oct. 17, 2017USD ($)$ / sharesshares	Nov. 28, 2018USD ($)$ / sharesshares	May 14, 2018USD ($)$ / sharesshares	Sep. 30, 2019USD ($)	May 07, 2019
Number of shares called by each warrants						1				1	1		1	1
Fair value of warrants | $										$ 64,431	$ 44,454		$ 70,026	$ 290,996
Number of common stock sold						334,000				345,166	206,000		187,483	1,150,500
Sales of stock price per share | $ / shares						$ 1				$ 0.60	$ 0.60		$ 1.20	$ 0.60
Cash consideration | $						$ 334,000				$ 207,004	$ 123,600		$ 224,980	$ 690,300
DUSA LLC [Member]
Number of warrants, exercisable					50,000
Warrants term					4 years
Number of shares called by each warrants					1
Exercise price | $ / shares					$ 0.01
Fair value of warrants | $					$ 94,999
Monthly fee | $					$ 15,000
Amir Uziel [Member]
Number of common stock sold												650,000
Sales of stock price per share | $ / shares												$ 0.01
Cash consideration | $												$ 26,000
One of Kind Kamami LLC [Member]
Number of common stock sold		500,000
MNSCO LLC [Member]
Number of common stock sold		5,500,000
Volatility [Member] | DUSA LLC [Member]
Warrant fair value measurement input, percentage					390
Discount Rate [Member] | DUSA LLC [Member]
Warrant fair value measurement input, percentage					2.43
Class F Warrant [Member]
Warrants term						36 months
Number of shares called by each warrants						1
Class G Warrant [Member]
Warrants term						60 months
Number of shares called by each warrants						1
Class I Warrant [Member]
Warrants converted into shares				99,576
Chairman and CEO [Member] | Class F Warrant [Member]
Number of warrants, exercisable	150,000
Warrants term	3 years
Number of shares called by each warrants	1
Exercise price | $ / shares	$ 3
Fair value of warrants, vested | $	$ 329,716														$ 27,476
Chairman and CEO [Member] | Class F Warrant [Member] | Volatility [Member]
Warrant fair value measurement input, percentage	389
Chairman and CEO [Member] | Class F Warrant [Member] | Discount Rate [Member]
Warrant fair value measurement input, percentage	2.28
Chairman and CEO [Member] | Class G Warrant [Member]
Number of warrants, exercisable	100,000
Warrants term	5 years
Number of shares called by each warrants	1
Exercise price | $ / shares	$ 5
Fair value of warrants, vested | $	$ 219,968														36,661
Chairman and CEO [Member] | Class G Warrant [Member] | Volatility [Member]
Warrant fair value measurement input, percentage	389
Chairman and CEO [Member] | Class G Warrant [Member] | Discount Rate [Member]
Warrant fair value measurement input, percentage	2.30
Chairman and CEO [Member] | Class H Warrant [Member]
Number of warrants, exercisable	150,000
Warrants term	5 years
Number of shares called by each warrants	1
Exercise price | $ / shares	$ 1
Fair value of warrants, vested | $	$ 329,979														54,996
Chairman and CEO [Member] | Class H Warrant [Member] | Volatility [Member]
Warrant fair value measurement input, percentage	389
Chairman and CEO [Member] | Class H Warrant [Member] | Discount Rate [Member]
Warrant fair value measurement input, percentage	2.30
Chairman and CEO [Member] | Class I Warrant [Member]
Number of warrants, exercisable	250,000
Warrants term	2 years
Number of shares called by each warrants	1
Exercise price | $ / shares	$ 0.01
Fair value of warrants, vested | $	$ 549,945														91,658
Chairman and CEO [Member] | Class I Warrant [Member] | Volatility [Member]
Warrant fair value measurement input, percentage	389
Chairman and CEO [Member] | Class I Warrant [Member] | Discount Rate [Member]
Warrant fair value measurement input, percentage	2.28
General Manager [Member] | Class I Warrant [Member]
Number of warrants, exercisable	250,000
Warrants term	2 years
Number of shares called by each warrants	1
Exercise price | $ / shares	$ 0.01
Fair value of warrants | $	$ 549,855
General Manager [Member] | Class I Warrant [Member] | Volatility [Member]
Warrant fair value measurement input, percentage	389
General Manager [Member] | Class I Warrant [Member] | Discount Rate [Member]
Warrant fair value measurement input, percentage	2.31
Chief Executive Officer and Sole Director [Member] | Maximum [Member]
Ownership percentage		10.00%														10.00%
One Officer [Member] | Class I Warrant [Member]
Number of warrants, exercisable							300,000
Warrants term							3 years
Number of shares called by each warrants				100,000
Exercise price | $ / shares							$ 0.01
Warrants vested description							The warrants vest one third immediately, one third on December 31, 2019 and one third on December 31, 2020
One Officer [Member] | Class J Warrant [Member]
Number of warrants, exercisable							300,000
Warrants term							3 years
Exercise price | $ / shares							$ .30
Warrants vested description							The warrants vest one third immediately, one third on December 31, 2019 and one third on December 31, 2020
Warrants converted into shares			87,500
One Officer [Member] | Class I and J Warrant [Member]
Fair value of warrants, vested | $							$ 449,898								$ 149,966
One Officer [Member] | Class I and J Warrant [Member] | Volatility [Member]
Warrant fair value measurement input, percentage							394
One Officer [Member] | Class I and J Warrant [Member] | Discount Rate [Member]
Warrant fair value measurement input, percentage							2.47
Three Consultants [Member] | Class I Warrant [Member]
Number of warrants, exercisable								450,000	450,000
Warrants term								2 years	2 years
Number of shares called by each warrants								1	1
Exercise price | $ / shares								$ 0.01	$ 0.01
Fair value of warrants | $									$ 719,774
Three Consultants [Member] | Class I Warrant [Member] | Separate Service Agreements [Member]
Number of warrants, exercisable								450,000	450,000
Warrants term								2 years	2 years
Number of shares called by each warrants								1	1
Exercise price | $ / shares								$ 0.01	$ 0.01
Fair value of warrants | $								$ 719,774
Related party description								The entities are considered related parties as they are more than 5% shareholders or are controlled by individuals who are more than 5% shareholders.
Three Consultants [Member] | Class I Warrant [Member] | Volatility [Member]
Warrant fair value measurement input, percentage								390	390
Three Consultants [Member] | Class I Warrant [Member] | Volatility [Member] | Separate Service Agreements [Member]
Warrant fair value measurement input, percentage								390	390
Three Consultants [Member] | Class I Warrant [Member] | Discount Rate [Member]
Warrant fair value measurement input, percentage								2.72	2.72
Three Consultants [Member] | Class I Warrant [Member] | Discount Rate [Member] | Separate Service Agreements [Member]
Warrant fair value measurement input, percentage								2.72	2.72
Three Consultants [Member] | Class J Warrant [Member]
Number of warrants, exercisable								750,000	750,000
Warrants term								3 years	3 years
Number of shares called by each warrants								1	1
Exercise price | $ / shares								$ 0.30	$ 0.30
Fair value of warrants | $									$ 1,199,643
Three Consultants [Member] | Class J Warrant [Member] | Separate Service Agreements [Member]
Number of warrants, exercisable								750,000	750,000
Warrants term								3 years	3 years
Number of shares called by each warrants								1	1
Exercise price | $ / shares								$ 0.30	$ 0.30
Fair value of warrants | $								$ 1,199,643
Related party description								The entities are considered related parties as they are more than 5% shareholders or are controlled by individuals who are more than 5% shareholders.
Three Consultants [Member] | Class J Warrant [Member] | Volatility [Member]
Warrant fair value measurement input, percentage								390	390
Three Consultants [Member] | Class J Warrant [Member] | Volatility [Member] | Separate Service Agreements [Member]
Warrant fair value measurement input, percentage								390	390
Three Consultants [Member] | Class J Warrant [Member] | Discount Rate [Member]
Warrant fair value measurement input, percentage								2.73	2.73
Three Consultants [Member] | Class J Warrant [Member] | Discount Rate [Member] | Separate Service Agreements [Member]
Warrant fair value measurement input, percentage								2.73	2.73